Answers are grounded in this paper and cite their sources.
Schizophrenia is a complex neurodevelopmental disorder characterized by positive, negative, and cognitive symptoms. While classical dopaminergic models explain psychotic features, they fail to address the debilitating negative and cognitive deficits that dictate long-term disability. We aim to synthesize contemporary evidence on the impairment of the excitatory/inhibitory (E/I) balance within cortical microcircuits as a central pathophysiological hypothesis of the disorder. The cascade is hypothesized to be driven by N-methyl-D-aspartate (NMDA) receptor hypofunction, which impairs parvalbumin-positive (PV+) interneurons and consequently downregulates glutamic acid decarboxylase (GAD67)-mediated gamma-aminobutyric acid (GABA) synthesis. Weakened PV+ interneuron function disrupts Pyramidal-Interneuron Network Gamma (PING) dynamics, reducing gamma-band synchronization and fronto-temporo-thalamic connectivity. At the macroscopic and cellular levels, the E/I imbalance is linked to reduced neuropil volume and aberrant synaptic pruning that disturbs dendritic architecture. Clinically, this triggers severe working memory dysfunction, cognitive rigidity, avolition, and anhedonia. This paper presents emerging glutamatergic and GABAergic pharmacological strategies, including glycine, D-serine, and metabotropic glutamate receptor (mGluR) modulators. We highlight key directions for future research, emphasizing the use of translational biomarkers (e.g., mismatch negativity (MMN), magnetic resonance spectroscopy (MRS), and gamma oscillations) to normalize PV+ interneuron function and network-level synchronization.
No takes yet. Share an insight, caveat, or question.
Zakrzewska et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: